Article Information
vol. 20 no. 121 201-207
PubMed
Published By
Print ISSN
Online ISSN
History
- Received February 15, 2011
- Accepted March 3, 2011
- Published online August 31, 2011.
Copyright & Usage
©ERS 2011
Author Information
- U. Costabel⇓
- U. Costabel, Ruhrlandklinik Essen, Universitätsklinik, Tüschener Weg 40, 45239 Essen, Germany. E-mail: ulrich.costabel{at}ruhrlandklinik.uk-essen.de
Article usage
Altmetrics
Vol 20 Issue 121
Table of Contents
Emerging potential treatments: new hope for idiopathic pulmonary fibrosis patients?
Jump To
- Article
- Abstract
- PHARMACOLOGICAL THERAPIES FOR IPF: CURRENT STATUS
- TRIPLE THERAPY WITH PREDNISONE, AZATHIOPRINE AND N-ACETYLCYSTEINE
- PIRFENIDONE
- JAPANESE PHASE II AND III TRIALS
- STUDIES 004 AND 006: EUROPEAN AND NORTH AMERICAN PHASE III TRIALS
- EXPLORATORY POOLED ANALYSIS OF STUDIES 004 AND 006
- SAFETY AND TOLERABILITY OF PIRFENIDONE IN STUDIES 004 AND 006
- META-ANALYSIS OF PHASE III STUDIES
- PROGNOSTIC FACTORS FOR IPF AND ASSESSMENT OF NEW TREATMENT OPTIONS
- SUMMARY
- Acknowledgments
- Footnotes
- REFERENCES
- Figures & Data
- Info & Metrics